Analyst Ranking
Top 15%
#825 out of 5496 analysts
Average Return
+20.74%
Win Rate
69%25 out of 36
Risk vs Reward
Poor
Good

Jason N. Butler's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Precigen IncPGEN
+103.42%$3.22$6.55
2025-08-19 -
2026-08-17
Buy
Rapport Therapeutics IncRAPP
+88.70%$25.66$48.42
2025-11-07 -
2026-08-17
Buy
Gh Research PLCGHRS
+88.20%$15.93$29.98
2026-03-06 -
2026-08-17
Buy
Precigen IncPGEN
+68.38%$3.89$6.55
2026-03-26 -
2026-08-17
Buy
Abivax SaABVX
+66.52%$72.50$120.73
2026-06-02 -
2026-08-17
Buy

Jason N. Butler Analyst Color

Get additional color on Jason N. Butler's coverage of popular stocks

Jason N. Butler's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Leonabio IncLONA
2Buy$17.00+120.49%Maintains
2 days ago
Halozyme Therapeutics IncHALO
1Buy$93.00-9.71%Maintains
12 days ago
Cytokinetics IncCYTK
2Buy$110.00+44.98%Maintains
12 days ago
Zevra Therapeutics IncZVRA
2Buy$28.00+142.84%Maintains
13 days ago
Acadia Pharmaceuticals IncACAD
4Buy$36.00+24.10%Maintains
14 days ago
Argenx SeARGX
2Buy$932.00-5.65%Maintains
a month ago
Abivax SaABVX
4Buy$187.00+54.89%Reiterates
2 months ago
Rezolute IncRZLT
2Buy$11.00+135.04%Upgrades
3 months ago
Gh Research PLCGHRS
2Buy$39.00+30.09%Maintains
3 months ago
Precigen IncPGEN
3Buy$11.00+67.94%Maintains
3 months ago
Avalo Therapeutics IncAVTX
2Buy$55.00+175.69%Maintains
3 months ago
Prothena Corp Public Ltd CoPRTA
1Buy$20.00+125.23%Maintains
3 months ago
Cormedix IncCRMD
2Buy$19.00+147.72%Reiterates
4 months ago
Minerva Neurosciences IncNERV
1Buy$14.00+216.74%Initiates Coverage On
4 months ago
Nasus Pharma LtdNSRX
1Buy$18.00+386.49%Maintains
5 months ago
Esperion Therapeutics IncESPR
1Buy$5.00+57.23%Maintains
5 months ago
Ironwood Pharmaceuticals IncIRWD
1Buy$10.00+129.36%Maintains
6 months ago
Achieve Life Sciences IncACHV
1Buy$19.00+153.33%Initiates Coverage On
9 months ago
Rapport Therapeutics IncRAPP
1Buy$80.00+65.22%Maintains
9 months ago
Terawulf IncWULF
1Buy$22.00+25.00%Maintains
10 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.